Postfach 8494 Bauma
Telephone: +41 55 212 23 24
Schircks Laboratories, Switzerland was founded by Dr. B. Schircks in 1980 to synthesize pteridines. The company is independently owned and operated. Schircks Laboratories has ceased production of tetrahydrobiopterin. Biomarin has taken over the US market and Merck Serono the European market. They will continue to expand. They are responsible for the supply of tetrahydrobiopterin (Sapropterin dihydrochloride) in tablet form (Kuvan).
Over 100 other pteridines are synthesized by Schircks Laboratories which are mainly used in science and clinical diagnostic applications. We are constantly developing and improving syntheses and starting new syntheses to meet the demands of research and development groups worldwide.
Please note that this website is continually updated and the price lists found here are always valid. Our price lists are not changed on a yearly basis but are valid from the date noted until further notice.
We welcome all suggestions per mail including other links youd like to see added.